Research
Press
November 6, 2024
December 7, 2021

Noninvasive Scale Measurement of Stroke Volume and Cardiac Output Compared With the Direct Fick Method: A Feasibility Study, Journal of American Heart Failure, JAHA

With this research, we demonstrate that a connected cardiac scale is able to approximate stroke volume and cardiac output compared to the direct Fick method. The Bodyport Cardiac Scale has the potential to be deployed in the home setting to easily and longitudinally monitor cardiac function.

Download the PDF

Link to Paper

Bodyport is a biomarker-guided digital therapeutics company on a mission to address complex chronic conditions by collecting clinically actionable biomarkers from simple, daily experiences. Bodyport captures hemodynamic signals through the Cardiac Scale to power optimized interventions tailored to the patient. By not requiring a wearable device or surgical implant, the solution seamlessly integrates into a patient’s daily life. Bodyport is focused on keeping patients with cardiorenal conditions healthier and out of the hospital. Based in San Francisco, the company is backed by top-tier investors such as Boehringer Ingelheim Venture Fund, Initialized Capital, Playground Global, Rock Health, and Y Combinator. For more information, visit bodyport.com and follow the company on LinkedIn and Twitter.